BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence

L Scarfò;S Bonfiglio;L A Sutton;V Ljungstrom;T Pandzic;D Cortese;G Gaidano;L Trentin;L Bonello;G Reda;P Panayiotidis;F Forconi;N Stavroyianni;C Bödör;C Tam;S Iyengar;A Österborg;M Coscia;L Ysebaert;O Jaksic;I Ringshausen;S Mulligan;A Tedeschi;V Strugov;Z Davis;C Pavlovsky;R Marasca;A Capasso;P Ranghetti;K Stamatopoulos;R Rosenquist;P Ghia

2020-01-01